Skip to Main Content

Author Details

Ashton A Connor
Houston Methodist Hospital
2012
37
19
PMIDPaper TitleJournal TitlePublished Year
37517983Liver transplantation as an alternative for the treatment of intrahepatic cholangiocarcinoma: Past, present, and future directions.Hepatobiliary Pancreat Dis Int2024
36900226Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology.Cancers (Basel)2023
37096152Progress in Combined Liver-lung Transplantation at a Single Center.Transplant Direct2023
34789870Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data.Nat Rev Cancer2022
36479082Intrahepatic cholangiocarcinoma: The role of liver transplantation, adjunctive treatments, and prognostic biomarkers.Front Oncol2022
35258509A Multidimensional Bioinformatic Platform for the Study of Human Response to Surgery.Ann Surg2022
34824045Impact of Research Training on Performance in General Surgery Residency.J Surg Educ2022
34336351Spontaneous Ureterocolic Fistula between Nonfunctioning Kidney Transplant Ureter and Colon in Setting of Diverticulitis.Case Rep Transplant2021
34159159A simple scoring system to estimate perioperative mortality following liver resection for primary liver malignancy-the Hepatectomy Risk Score (HeRS).Hepatobiliary Surg Nutr2021
32951852Decreased graft loss following implementation of the kidney allocation score (KAS).Am J Surg2020
31964786A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer.Clin Cancer Res2020
31932696Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution.Nat Genet2020
32051610Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution.Nat Genet2020
31797378A clinical-radiomic model for improved prognostication of surgical candidates with colorectal liver metastases.J Surg Oncol2020
33425425Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint Inhibitor.Case Rep Urol2020
32773623Outcomes in Kidney Transplantation Between Veterans Affairs and Civilian Hospitals: Considerations in the Context of the MISSION Act.Ann Surg2020
30686769Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.Cancer Cell2019
29288237Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial.Clin Cancer Res2018
35135108Reflex Testing for Germline <i>BRCA1</i>, <i>BRCA2</i>, <i>PALB2</i>, and <i>ATM</i> Mutations in Pancreatic Cancer: Mutation Prevalence and Clinical Outcomes From Two Canadian Research Registries.JCO Precis Oncol2018
29378198Mutations in Mitochondrial DNA From Pancreatic Ductal Adenocarcinomas Associate With Survival Times of Patients and Accumulate as Tumors Progress.Gastroenterology2018
29074453Exome-Wide Association Study of Pancreatic Cancer Risk.Gastroenterology2018
27768182Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma.JAMA Oncol2017
28460572Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?Expert Rev Gastroenterol Hepatol2017
29133135Characterization, Detection, and Treatment Approaches for Homologous Recombination Deficiency in Cancer.Trends Mol Med2017
28718411Molecular Events in the Natural History of Pancreatic Cancer.Trends Cancer2017
27851734Erratum: A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.Nature2017
27086928Intestinal knockout of Nedd4 enhances growth of Apc<sup>min</sup> tumors.Oncogene2016
26546047Candidate DNA repair susceptibility genes identified by exome sequencing in high-risk pancreatic cancer.Cancer Lett2016
27732578A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.Nature2016
27019099Genetic testing for Lynch syndrome in the province of Ontario.Cancer2016
26714949Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver Metastases.Ann Surg Oncol2016
25380764Identification of a novel MSH6 germline variant in a family with multiple gastro-intestinal malignancies by next generation sequencing.Fam Cancer2015
26501191Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids.Nat Med2015
26363539Hereditary Pancreatic Cancer Syndromes.Surg Oncol Clin N Am2015
25864590Increased in vitro and in vivo sensitivity of BRCA2-associated pancreatic cancer to the poly(ADP-ribose) polymerase-1/2 inhibitor BMN 673.Cancer Lett2015
25479140Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.Gastroenterology2015
21989350Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.Am J Surg Pathol2012
  • 1 - 37 of 37

Recommended Authors

Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 0
College of Medicine, University of Florida
Career Start Year 2014
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2014
Number of shared co-authors 12
Research Triangle Institute (RTI)
Career Start Year 2009
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 1
Garvan Institute of Medical Research and The Kinghorn Cancer Centre
Career Start Year 2009
Number of shared co-authors 15
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year 2008
Number of shared co-authors 1
University of Basel
Career Start Year 2008
Number of shared co-authors 9
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 1
Tisch Cancer Institute, Mount Sinai Hospital
Career Start Year 2005
Number of shared co-authors 1
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 2
Moffitt Cancer Center
Career Start Year 2004
Number of shared co-authors 5
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 2
University of California
Career Start Year 2003
Number of shared co-authors 4
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 4
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 0
Uppsala University
Career Start Year 1999
Number of shared co-authors 0
University of California san francisco
Career Start Year 1999
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 3
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 3
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 4
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 6
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 16
University of California San Diego Moores Cancer Center
Career Start Year 1992
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 1992
Number of shared co-authors 1
University of Pittsburgh
Career Start Year 1989
Number of shared co-authors 0
University of California San Diego
Career Start Year 1985
Number of shared co-authors 2
University of Colorado School of Medicine
Career Start Year 1983
Number of shared co-authors 14

Collaborators

Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers 25
Ontario Institute for Cancer Research
Co-authored papers 10
Ontario Institute for Cancer Research
Co-authored papers 10
2Ontario Institute for Cancer Research
Co-authored papers 9
Ontario Institute for Cancer Research
Co-authored papers 8
University of Edinburgh
Co-authored papers 8
University Health Network
Co-authored papers 7
Princess Margaret Cancer Centre
Co-authored papers 7
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 6
Mayo Clinic
Co-authored papers 6
The Hospital for Sick Children
Co-authored papers 5
Ontario Institute for Cancer Research
Co-authored papers 4
Ontario Institute for Cancer Research
Co-authored papers 4
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 4
Wellcome Sanger Institute
Co-authored papers 4
Moores Cancer Center, university of california san diego
Co-authored papers 3
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Nicklaus Children's Hospital
Co-authored papers 3
University Health Network, University of Toronto
Co-authored papers 3
Mount Sinai Hospital
Co-authored papers 3
Rutgers Robert Wood Johnson Medical School
Co-authored papers 2
Ontario Institute for Cancer Research
Co-authored papers 2
Ontario Institute for Cancer Research
Co-authored papers 2
Ontario Institute for Cancer Research
Co-authored papers 2
University of British Columbia
Co-authored papers 2
University of British Columbia
Co-authored papers 2
Ontario Institute for Cancer Research
Co-authored papers 2
Human Longevity Inc.
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Spanish National Cancer Research Centre-CNIO
Co-authored papers 2